{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:35:32Z","timestamp":1791920132890,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002560","name":"Soonchunhyang University","doi-asserted-by":"publisher","award":["20210499"],"award-info":[{"award-number":["20210499"]}],"id":[{"id":"10.13039\/501100002560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The risk factors of mild cognitive impairment (MCI) in patients with de novo Parkinson\u2019s disease (PD) remain unclear. Therefore, the objective of this study was to compare motor and non-motor symptoms between de novo patients with PD with and without MCI. Moreover, detailed relationships between each cognitive deficit and other clinical characteristics in de novo patients with PD were investigated. Consecutive patients with de novo PD were retrospectively enrolled in this study. Motor symptoms were assessed using the Unified Parkinson\u2019s Disease Rating Scale (UPDRS) part-III and the Hoehn and Yahr (HY) stage. Non-motor symptoms including depression, anxiety, fatigue, and autonomic dysfunction were measured using representative questionnaires. Motor symptoms, depression, and dysautonomia were associated with MCI in de novo patients with PD. Compared with the non-MCI group with PD, the MCI group with PD had higher scores of UPDRS-III, HY stage, depression, and dysautonomia, but not fatigue or anxiety. Both UPDRS-III and HY stage were significantly linked to all cognitive deficits except attention. Logistic regression analysis showed that depression was associated with memory, visuospatial, and executive impairment, and dysautonomia was related to visuospatial and executive impairment. The results of this study suggest that cognitive impairment in PD might have a different relationship pattern to the motor and some non-motor symptoms.<\/jats:p>","DOI":"10.1038\/s41598-022-15630-8","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T16:06:58Z","timestamp":1657123618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson\u2019s disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Kyum-Yil","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae On","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"15630_CR1","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","volume":"339","author":"AE Lang","year":"1998","unstructured":"Lang, A. E. & Lozano, A. M. Parkinson\u2019s disease. First of two parts. N. Engl. J. Med. 339, 1044\u20131045 (1998).","journal-title":"N. Engl. J. Med."},{"key":"15630_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira, A. H. V., Chaudhuri, K. R. & Jenner, P. Non-motor features of Parkinson disease. Nat. Rev. Neurosci. 18, 435\u2013450 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"15630_CR3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3389\/fneur.2020.00731","volume":"11","author":"A Simon-Gozalbo","year":"2020","unstructured":"Simon-Gozalbo, A. et al. Clinical characterization of Parkinson\u2019s disease patients with cognitive impairment. Front. Neurol. 11, 731 (2020).","journal-title":"Front. Neurol."},{"key":"15630_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12955-021-01740-w","volume":"19","author":"Y He","year":"2021","unstructured":"He, Y. et al. The path linking disease severity and cognitive function with quality of life in Parkinson\u2019s disease: the mediating effect of activities of daily living and depression. Health Qual. Life Outcomes 19, 92 (2021).","journal-title":"Health Qual. Life Outcomes"},{"key":"15630_CR5","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1093\/brain\/awp245","volume":"132","author":"CH Williams-Gray","year":"2009","unstructured":"Williams-Gray, C. H. et al. The distinct cognitive syndromes of Parkinson\u2019s disease: 5 year follow-up of the CamPaIGN cohort. Brain 132, 2958\u20132969 (2009).","journal-title":"Brain"},{"key":"15630_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.conb.2010.01.007","volume":"20","author":"AA Kehagia","year":"2010","unstructured":"Kehagia, A. A., Murray, G. K. & Robbins, T. W. Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr. Opin. Neurobiol. 20, 199\u2013204 (2010).","journal-title":"Curr. Opin. Neurobiol."},{"key":"15630_CR7","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","volume":"9","author":"AA Kehagia","year":"2010","unstructured":"Kehagia, A. A., Barker, R. A. & Robbins, T. W. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson\u2019s disease. Lancet Neurol. 9, 1200\u20131213 (2010).","journal-title":"Lancet Neurol."},{"key":"15630_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.27902","volume":"35","author":"C Baiano","year":"2020","unstructured":"Baiano, C. et al. Prevalence and clinical aspects of mild cognitive impairment in Parkinson\u2019s disease: A meta-analysis. Mov. Disord. 35, 45\u201354 (2020).","journal-title":"Mov. Disord."},{"key":"15630_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.cger.2020.01.001","volume":"36","author":"JG Goldman","year":"2020","unstructured":"Goldman, J. G. & Sieg, E. Cognitive Impairment and Dementia in Parkinson Disease. Clin. Geriatr. Med. 36, 365\u2013377 (2020).","journal-title":"Clin. Geriatr. Med."},{"key":"15630_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.14802\/jmd.16012","volume":"9","author":"KY Kwon","year":"2016","unstructured":"Kwon, K. Y. et al. Cognition and visit-to-visit variability of blood pressure and heart rate in De Novo patients with Parkinson\u2019s disease. J. Mov. Disord. 9, 144\u2013151 (2016).","journal-title":"J. Mov. Disord."},{"key":"15630_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.parkreldis.2017.05.020","volume":"41","author":"M Siciliano","year":"2017","unstructured":"Siciliano, M. et al. Cognitive impairment is associated with Hoehn and Yahr stages in early, de novo Parkinson disease patients. Parkinsonism Relat. Disord. 41, 86\u201391 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"15630_CR12","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"15630_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"15630_CR14","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1037\/neu0000583","volume":"33","author":"JD Jones","year":"2019","unstructured":"Jones, J. D. et al. Depressive symptoms precede cognitive impairment in de novo Parkinson\u2019s disease patients: Analysis of the PPMI cohort. Neuropsychology 33, 1111\u20131120 (2019).","journal-title":"Neuropsychology"},{"key":"15630_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/mds.25748","volume":"29","author":"MT Hu","year":"2014","unstructured":"Hu, M. T. et al. Predictors of cognitive impairment in an early stage Parkinson\u2019s disease cohort. Mov. Disord. 29, 351\u2013359 (2014).","journal-title":"Mov. Disord."},{"key":"15630_CR16","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1080\/13803395.2015.1073227","volume":"37","author":"LF Vasconcellos","year":"2015","unstructured":"Vasconcellos, L. F. & Pereira, J. S. Parkinson\u2019s disease dementia: diagnostic criteria and risk factor review. J. Clin. Exp. Neuropsychol. 37, 988\u2013993 (2015).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"15630_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40035-016-0058-0","volume":"5","author":"Y Xu","year":"2016","unstructured":"Xu, Y., Yang, J. & Shang, H. Meta-analysis of risk factors for Parkinson\u2019s disease dementia. Transl. Neurodegener. 5, 11 (2016).","journal-title":"Transl. Neurodegener."},{"key":"15630_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp-2014-310095","volume":"87","author":"JQ Li","year":"2016","unstructured":"Li, J. Q. et al. Risk factors for predicting progression from mild cognitive impairment to Alzheimer\u2019s disease: A systematic review and meta-analysis of cohort studies. J. Neurol. Neurosurg. Psychiatry 87, 476\u2013484 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"15630_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.parkreldis.2019.10.002","volume":"73","author":"SG Ryman","year":"2020","unstructured":"Ryman, S. G. & Poston, K. L. MRI biomarkers of motor and non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 73, 85\u201393 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"15630_CR20","volume":"2012","author":"R de la Fuente-Fern\u00e1ndez","year":"2012","unstructured":"de la Fuente-Fern\u00e1ndez, R. Frontostriatal cognitive staging in Parkinson\u2019s disease. Parkinsons Dis. 2012, 561046 (2012).","journal-title":"Parkinsons Dis."},{"key":"15630_CR21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/mds.26632","volume":"31","author":"C McDonald","year":"2016","unstructured":"McDonald, C., Newton, J. L. & Burn, D. J. Orthostatic hypotension and cognitive impairment in Parkinson\u2019s disease: Causation or association?. Mov. Disord. 31, 937\u2013946 (2016).","journal-title":"Mov. Disord."},{"key":"15630_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.parkreldis.2020.01.009","volume":"72","author":"JD Jones","year":"2020","unstructured":"Jones, J. D. et al. Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson\u2019s disease. Parkinsonism Relat. Disord. 72, 7\u201312 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"15630_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5056\/jnm17105","volume":"24","author":"AT Nair","year":"2018","unstructured":"Nair, A. T. et al. Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of Parkinson\u2019s disease: A critical review. J. Neurogastroenterol. Motil. 24, 30\u201342 (2018).","journal-title":"J. Neurogastroenterol. Motil."},{"key":"15630_CR24","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00702-016-1667-6","volume":"124","author":"N Titova","year":"2017","unstructured":"Titova, N. et al. Parkinson\u2019s: A syndrome rather than a disease?. J. Neural. Transm. (Vienna) 124, 907\u2013914 (2017).","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"15630_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"DJ Gelb","year":"1999","unstructured":"Gelb, D. J., Oliver, E. & Gilman, S. Diagnostic criteria for Parkinson disease. Arch. Neurol. 56, 33\u201339 (1999).","journal-title":"Arch. Neurol."},{"key":"15630_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2967\/jnumed.111.095224","volume":"53","author":"M Oh","year":"2012","unstructured":"Oh, M. et al. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy. J. Nucl. Med. 53, 399\u2013406 (2012).","journal-title":"J. Nucl. Med."},{"key":"15630_CR27","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1212\/WNL.40.10.1529","volume":"40","author":"J Jankovic","year":"1990","unstructured":"Jankovic, J. et al. Variable expression of Parkinson\u2019s disease: A base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40, 1529\u20131534 (1990).","journal-title":"Neurology"},{"key":"15630_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.14802\/jmd.20009","volume":"13","author":"KY Kwon","year":"2020","unstructured":"Kwon, K. Y. et al. Risk factors for falls in patients with de novo Parkinson\u2019s disease: A focus on motor and non-motor symptoms. J. Mov. Disord. 13, 142\u2013145 (2020).","journal-title":"J. Mov. Disord."},{"key":"15630_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/gps.1664","volume":"22","author":"SA Jo","year":"2007","unstructured":"Jo, S. A. et al. Usefulness of Beck Depression Inventory (BDI) in the Korean elderly population. Int. J. Geriatr. Psychiatry 22, 218\u2013223 (2007).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"15630_CR30","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2018.33.e128","volume":"33","author":"K Lee","year":"2018","unstructured":"Lee, K., Kim, D. & Cho, Y. Exploratory factor analysis of the beck anxiety inventory and the beck depression inventory-II in a psychiatric outpatient population. J. Kor. Med. Sci. 33, e128 (2018).","journal-title":"J. Kor. Med. Sci."},{"key":"15630_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.parkreldis.2004.07.007","volume":"11","author":"RG Brown","year":"2005","unstructured":"Brown, R. G. et al. The Parkinson fatigue scale. Parkinsonism Relat. Disord. 11, 49\u201355 (2005).","journal-title":"Parkinsonism Relat. Disord."},{"key":"15630_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/nhs.12332","volume":"19","author":"S Ahn","year":"2017","unstructured":"Ahn, S. et al. Uncertainty and depression in people with Parkinson\u2019s disease: A cross-sectional study. Nurs. Health Sci. 19, 220\u2013227 (2017).","journal-title":"Nurs. Health Sci."},{"key":"15630_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.14802\/jmd.16057","volume":"10","author":"JY Kim","year":"2017","unstructured":"Kim, J. Y. et al. Validation of the korean version of the scale for outcomes in Parkinson\u2019s disease-autonomic. J. Mov. Disord. 10, 29\u201334 (2017).","journal-title":"J. Mov. Disord."},{"key":"15630_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.12779\/dnd.2015.14.4.137","volume":"14","author":"S Jahng","year":"2015","unstructured":"Jahng, S., Na, D. L. & Kang, Y. Constructing a composite score for the Seoul neuropsychological screening battery-core. Dement Neurocogn. Disord. 14, 137\u2013142 (2015).","journal-title":"Dement Neurocogn. Disord."},{"key":"15630_CR35","unstructured":"Kang. Y., Jang, S., & Na, D.L. In: Seoul neuropsychological screening battery (SNSB-II). 2nd ed. Seoul: Human Brain Research & Consulting Co.; 2012."},{"key":"15630_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan, I. et al. Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov. Disord. 27, 349\u2013356 (2012).","journal-title":"Mov. Disord."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15630-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15630-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15630-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:25:57Z","timestamp":1669339557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15630-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15630"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15630-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"9 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11461"}}